Skip to main content
. 2024 Jan 29;14(3):287. doi: 10.3390/diagnostics14030287

Figure 3.

Figure 3

Molecular activity prediction analysis of the bio-functions metastasis, anoikis, and senescence of tumor cells related to the TNBC subtype. The figures show the downregulation of TP53, RB1, and PTEN secondary to loss of function mutations. This mutation predicts activated metastasis and inhibits tumor cells’ anoikis and senescence. CP = canonical pathway. Rx = drug being tested in clinical trials.